Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Details Narrative)

v3.25.3
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Nov. 10, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Product Information [Line Items]            
Allowance for doubtful accounts   $ 278,201   $ 278,201   $ 278,201
Net loss   1,166,375 $ (1,441,927) 3,923,401 $ 1,238,776  
Accumulated deficit   29,705,709   29,705,709   $ 25,782,308
Negative cash flow from operating activities       3,709,104 $ 3,658,901  
Cash equivalents and short-term investments   $ 454,432   $ 454,432    
Subsequent Event [Member]            
Product Information [Line Items]            
Proceeds from Issuance or Sale of Equity $ 6,000,000          
Total Purchases [Member] | Product Concentration Risk [Member] | Major Vendor [Member]            
Product Information [Line Items]            
Concentration risk percentage       76.00%